Frontiers17d
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
1 Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy 2 Azienda Ospedaliero-Universitaria di Cagliari, Cagliari, Italy Dupilumab is a monoclonal antibody targeting ...
Frontiers21d
Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study
Conclusion: Dupilumab has a good safety profile in Chinese children ... Among the ADRs outcomes, 10 cases (15.38%) showed improvement (including 2 cases of allergic conjunctivitis, 4 cases of ...